ECO Animal Health Group (LON:EAH) Stock Price Passes Below Two Hundred Day Moving Average – What’s Next?

ECO Animal Health Group plc (LON:EAH)’s share price crossed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 98.91 ($1.25) and traded as low as GBX 68.08 ($0.86). ECO Animal Health Group shares last traded at GBX 69 ($0.87), with a volume of 184,678 shares trading hands.

Wall Street Analysts Forecast Growth

Separately, Shore Capital reiterated a “buy” rating on shares of ECO Animal Health Group in a research report on Friday, November 29th.

ECO Animal Health Group Trading Down 2.1 %

The firm has a market capitalization of £46.74 million, a P/E ratio of 3,450.00 and a beta of -0.05. The company has a quick ratio of 2.14, a current ratio of 2.96 and a debt-to-equity ratio of 4.31. The firm’s 50-day simple moving average is GBX 69.91 and its 200-day simple moving average is GBX 98.91.

Insider Buying and Selling at ECO Animal Health Group

In other ECO Animal Health Group news, insider David Hallas acquired 15,500 shares of the stock in a transaction dated Monday, December 2nd. The stock was purchased at an average cost of GBX 74 ($0.93) per share, for a total transaction of £11,470 ($14,476.84). 21.65% of the stock is currently owned by company insiders.

About ECO Animal Health Group

ECO Animal Health Group plc, together with its subsidiaries, develops, registers, and markets pharmaceutical products for animals worldwide. The company provides Aivlosin, a macrolide antibiotic for the treatment of enteric and respiratory diseases in pigs and poultry. It also offers generic drugs, such as Ecomectin, Ecoheart, Ecotraz, and Ecomintic, which are endectocides and other antiparasitics for the treatment and prevention of parasites, such as worms, ticks, mange, and lices in cattle, sheep, pigs, horses, and dogs; and Chlortetracycline and Oxytetracycline for treatment of bacterial infections in pigs, poultry, and cattle.